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Abstract
Introduction: Pelvic surgery is challenging and impacts significantly on limb and visceral function,
thus, raising the question "is heroic surgery justifiable". This study assessed the functional, oncologic
and surgical outcomes following pelvis tumour resections.
Methods:  Between 1996–2003, 49 patients (mean age 43 years) underwent pelvic tumour
resections- 38 primary malignant tumours, 5 secondary tumours and 6 benign tumours. Bone
tumours comprised 5 osteosarcomas, 5 Ewings sarcomas, and 12 chondrosarcomas. Of the soft
tumours, 9 were of neural origin. Tumours involved the ilium, acetabulum, pubic bones, sacrum or
a combination of these. Functional assessment was performed and no patient had metastases at
presentation.
Results: There were 41 limb sparing resections and 8 hindquarter amputations. Surgical margins
were intralesional (1), marginal (13), wide (26), and radical (3). Of limb sparing surgery, prosthetic
reconstructions were performed in 10 patients, biologic reconstructions in 6, a combination of
these in 3 and no reconstruction in others. There was 1 intraoperative death, 7 local recurrences
and 19 metastases. Death from disease occurred at a mean of 14.2 months with a mean followup
of 27 (1–96) months. Amputation and periacetabular resections had worse functional outcomes.
Emotional acceptance was surprisingly high.
Conclusion: Pelvic resections are complex. Functional outcome is significantly affected by surgery.
Disease control is similar to limb tumours. Emotional acceptance of surgery in survivors was
surprisingly high. Major pelvic resection for malignancy appears justified.
Background
Pelvic resection is challenging and can have significant
functional, social and psychological impact on the
patient. It is also associated great morbidity especially
when extensive resection is required to attain adequate
surgical margins. With the introduction of adjuvant chem-
otherapy and radiotherapy, and improved reconstruction
techniques, limb- sparing surgery has largely replaced
external hemipelvectomy. However, given the often poor
prognosis of patients with pelvic tumours, the question of
whether this type of surgery is justified remains unan-
swered. This study assessed the functional, oncologic and
surgical outcomes following pelvic tumour resection.
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Methods
Patients
From 1996 to 2003, 49 patients at St. Vincent's Hospital
underwent pelvic tumour resections. Clinical and func-
tional information on all 49 patients were available for
review. There were 25 males and 24 females. The mean
age was 43.2 (15 – 72) years. 38 patients underwent sur-
gery for primary malignancy, 6 patients for benign
tumour, while 5 patients had surgery for metastasis.
Tumour characteristics
Of the 38 primary malignancy cases, there were 5 osteosa-
rcomas, 5 Ewing sarcoma, and 12 chondrosarcoma. Of
the 5 metastatic tumours, there was 1 colorectal cancer, 1
vulvar cancer, 1 renal cell cancer, 1 squamous cell cancer
and one Lung cancer. The histological subgroup is sum-
marised in Table 1.
According to the Enneking's classification, one patient
had stage 1A tumour, one patient had stage 1B tumour, 6
patients had stage 2A tumours and 30 patients had 2B
tumours.
Tumours involved the ilium (P1), the periacetabular
region (P2) with or without involvement of the proximal
femur (H1), the pubis (P3), the sacrum (P4) or a combi-
nation of these. The location and the corresponding histo-
logical subgroup is summarised in Table 2.
Operations
Pelvic resections were classified according to Enneking
and Dunham into 4 types; namely, iliac (T1), acetabular
(T2), pubis or ischium (T3) and sacral (T4). Combina-
tions of these resections with or without high femoral
resection (H1) were also performed (Figure 1).
The types of resection and the methods of reconstruction
are summarised in Table 3.
The surgical margins achieved were classified according to
the criteria established by the Musculoskeletal Tumour
society; namely intralesional, marginal, wide, and radical.
Adjuvant Treatment
9 patients received chemotherapy alone, 6 received radio-
therapy alone, and 6 patients received both chemotherapy
and radiotherapy.
Follow-up
Follow – up was calculated from the time of surgery to the
last date of review or death. The series was updated by
reviewing the clinical charts of the patients. In addition, a
standardized questionnaire regarding clinical outcome
and function was completed for every patient by way of
phone interview. Evaluation of disease status and func-
tional result at last follow-up review was performed for all
patients. The mean length of follow-up was 27 months (1
to 96 months). The distribution of the follow-up period is
summarised in Figure 2.
Functional assessment
Function was assessed by the modified function evalua-
tion system recommended by Enneking et al [1] With this
system, functional assessment is based on an analysis of
factors (pain, functional activities, emotional acceptance)
pertinent to the patient as a whole and factors specific to
the lower limb (use of external supports, walking ability,
and gait). For each of the six factors, values of 0 to 5 are
assigned on the basis of established criteria. Descriptive
Table 1: Tumour Types
Primary Tumours Number
Central osteosarcoma 1
Chondroblastic osteosarcoma 4
Paget's Osteosarcoma 1
Undifferentiated sarcoma 1
Ewing Sarcoma 5
Chondrosarcoma 12
Chordoma 4
MFH 4
Desmoid tumour 1
Leiomyosarcoma 1
Malignant periphereal nerve sheath tumour 1
Spindle cell carcinoma 1
Neurofibrosarcoma 1
Rhabdomyosarcoma 1
Neurofibroma 1
Osteochondroma 2
Schwannoma 2
Chondromyxoid fibroma 1
Secondary Tumours
Colorectal 1
Vulvar 1
Renal cell cancer 1
Squamous cell carcinoma 1
neuroendocrine cancer from the lung 1
Table 2: Location in relation to type of tumour
P1 P1/2 P2 P2/H1 P2/3 P3 P4 P1/4
B E N I G N 300 0 00 30
SARCOMA 5 4 4 4 9 2 5 5
CARCINOMA 1 0 1 0 1 2 0 0International Seminars in Surgical Oncology 2005, 2:9 http://www.issoonline.com/content/2/1/9
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terms like excellent, good, fair or poor are assigned to a
specific numerical range. (26–30 Excellent, 21–25 Good,
16–20 Satisfactory, 11–15 Fair, and 10 or less Poor)
Results
Duration of surgery
The mean operative time was 5.2 (1.5 – 10) hours.
Blood loss
The mean number of packed cell units for intra-operative
transfusion was 10 (2 – 26) units.
Length of stay
The mean length of in – hospital stay was 23 (2 – 110)
days.
Oncologic Outcome
Of the 5 patients who underwent surgery for metastatic
carcinoma, marginal margins were achieved in 3 patients,
and wide margins were achieved in the other 2 patients.
Of the 38 patients who underwent surgery for sarcoma,
intralesional margin was achieved in 1 patient, marginal
margins were achieved in 10 patients, wide margins were
achieved in 24 patients and radical margins were achieved
in 3 patients.
The oncologic outcomes in relation to tumour type, previ-
ous biopsy and surgical margin are shown in Table 4. 7
patients had local recurrence. 19 patients developed
metastasis. 19 patients died of disease. The mean survival
of these patients was 14.2 (1 – 51) months.
Complications
22 of the 49 patients had complications.
There was one intraoperative death.
3 patients had common peroneal nerve palsy and 1
patient had sciatic nerve palsy. 2 patients had urinary
incontinence and 1 patient had erectile dysfunction after
Type 4 pelvic resection.
14 patients had wound infections: 2 of these were super-
ficial infections and 12 were deep infections.
1 patient had a wound hematoma.
3 patients had dislocation/disarticulation of the saddle
prosthesis.
3 patients after external hemipelvectomy had phantom
limb pain.
13 patients required additional surgeries. 6 of these
patients required open drainage or debridement of
infected wound. 1 patient required removal of prosthesis
due to infection. 2 patients required subsequent split-skin
An illustration of the types of pelvic resection Figure 1
An illustration of the types of pelvic resection.
Table 3: Types of resection and Methods of reconstruction
T1 T1/2 T2 T2/H1 T2/3 T3 T4 T1/4
Limb Sparing Surgery (41) 7 3 0 3 9 3 7 7
Amputation (8) 8
Reconstruction (19) 1 FVFG 1 pelvic 
reconstruction 
with bone cement
3 ischiofemoral 
pseudoarthrodesis
2 pelvic allograft with 
hip arthroplasty 1 
saddle prosthesis 
with reconstruction 
plate
8 saddle 
prosthesis 1 
pelvic allograft 
with hip 
arthroplasty
1 FVFG 1 
ischiofemoral 
pseudoarthrodesisInternational Seminars in Surgical Oncology 2005, 2:9 http://www.issoonline.com/content/2/1/9
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A bar graph showing the distribution of the follow-up periods Figure 2
A bar graph showing the distribution of the follow-up periods.
Table 4: Oncologic outcome in relation to surgical margin, tumour type and previous biopsy.
MARGINS
CARCINOMA n L.R. Prev. Biopsy Mets
I N T R A L E S I O N A L 0000
M A R G I N A L 3111
W I D E 2002
SARCOMA
I N T R A L E S I O N A L 1111
M A R G I N A L 1 0 313
WIDE 24 2 1 9
R A D I C A L 3003International Seminars in Surgical Oncology 2005, 2:9 http://www.issoonline.com/content/2/1/9
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graft. 2 patients required subsequent rectus flaps. 1 patient
required a rhomboid flap. 1 patient required a Latissimus
Dorsi flap but due to recurrent wound infections subse-
quently underwent external hemipelvectomy.
The complications in relation to the type of pelvic resec-
tion are shown in Table 5.
Functional Outcome
The outcomes for 44 patients were assessed. According to
the criteria of Enneking et al [1], 11 patients had excellent
functional results, 7 patients had good functional results,
9 patients had satisfactory functional results, 5 patients
had fair functional results, and 12 patients had poor
results.
The functional results in relation to the performed surgi-
cal procedure are shown in Table 6.
Of the internal hemipelvectomy, Type 3 and Type 4 pelvic
resections have the best mean overall functional scores
and are both in the range of excellent functional result.
On the other hand, combined type 2 and 3 resection has
the worst mean overall functional score and falls in the
range of fair functional result.
The mean overall function score for external hemipelvec-
tomy falls in the range of poor functional result.
When the emotional acceptance score is excluded from
the overall functional score, Type 3 and Type 4 pelvic
resections still have the best total score. Resections
involving the hip joint (i.e. T1/2, T2/H1, and T2/3) all
scored below 60% of the total.
All internal hemipelvectomy have mean emotional
acceptance score of greater than 4 except combined type 2
and 3 pelvic resection, combined type 1 and 4 resection,
and type 4 resection. (They scored 2.7, 3.3 and 3.9
respectively)
External hemipelvectomy has the lowest mean emotional
acceptance score.
Discussion
Pelvic resections are complex. They are technically diffi-
cult due to the usually large size of pelvic tumours, and
the close proximity of pelvic viscera and neurovasculature
of the pelvis and lower limb. The technical and human
resources required are intensive. Patients often require
large amount of blood products. They require post-opera-
tive recovery in ICU and in most cases long periods of in-
Table 5: Types of resection and complications
T1 T1/2 T2 T2/H1 T2/3 T3 T4 T1/4 AMP Total
Infection 2 3 1 1 2 5 14
Hematoma 11
skin/flap problem 22
Venous thrombus 1 1 2
nerve injury 1 1 2 1 5
Phantom limb pain 33
Urinary incontinence 22
Erectile dysfunction 11
Prosthetic dislocation 3 3
Require additional surgery 1 3 1 2 2 4 13
Table 6: Functional Result in relation to surgical of procedure
T1 T1/2 T2 T2/H1 T2/3 T3 T4 T1/4 AMP
Mean Functional Score 22.8 19.3 18 12 27 25 19 5
Range (12 – 29) (19 – 20) (15 – 21) (3 – 18) (15 – 30) (8 – 28) (0 – 10)
Emotional Acceptance 4.5 4.3 4.5 2.7 4.5 3.9 3.3 2
Functional score excluding the 
emotional acceptance component
18.3 (73.2%) 15 (60%) 13.5 (54%) 9.3 (37.2%) 22.5 (90%) 21.1 (84.4%) 15.7 (62.8%) 3 (12%)International Seminars in Surgical Oncology 2005, 2:9 http://www.issoonline.com/content/2/1/9
Page 6 of 8
(page number not for citation purposes)
patient rehabilitation. Most importantly, the diagnosis
and management of pelvic tumour require a multidiscipli-
nary approach, which includes radiologist, oncologist,
physiotherapist, Occupation therapist, and Orthotist.
Hence, patients must be treated in specialised centres
where such resources are available.
As shown in our series, the morbidity is great with a high
risk of wound infection and nerve injury. The overall com-
plication rate has been reported as high as 50–60% [2]. In
the current series, 22 out of 49 patients (45%) had com-
plications. Regardless of the type of resection, there is a
significant functional, social and psychological impact on
the patient. Moreover, there is a significant risk of peri -
operative mortality.
Because of these issues, there remains the question as to
whether pelvic surgery performed with curative intent or
for palliation is justified particularly for patients with high
grade malignancy where the prognosis is poor. However,
the results of the current series show that this type opera-
tion may be worthwhile.
In regards to oncologic outcome, forty out of the forty-
nine patients survived longer than six months. The mean
survival was greater than one year. The local failure rate
was 16%, and 40% of patients developed metastasis.
These figures are supported by Pring et al [3] who reported
a similar local failure rate of 19% and an overall survival
rate of 69%. Ozaki et al [4] reported a higher local recur-
rence rate of 60% and a poorer 5-year survival rate of 27%.
However, in that study only patients with osteosarcoma
were studied and 70% of patients had inadequate surgical
margin. Disease control by pelvic resection is comparable
to that of surgery for limb tumors. Bacci et al [5] reported,
in his series of 526 patients with osteosarcoma of the
extremities, a local recurrence rate of 6% and an overall
survival rate of 70%. Sluga M et al [6] in his series of 130
patients also found a comparable LR rate of 2.3% and OS
of 71% for limb-sparing surgery. The comparable onco-
logic result of pelvic resection to surgery for limb tumours
is surprising because the response of pelvic tumors to
adjuvant therapy is generally poor and the adequacy of
surgical margin difficult to achieve.
The functional outcome varied with the level of resection
but more than 50% of patients had satisfactory or better
overall functional results in the current series. This is sup-
ported by Wirbel et al [7] who also found more than 60%
of patients had good or excellent functional results in his
series of 93 patients.
In the current study, we observed, not surprisingly, a sig-
nificantly worse functional score in patients who had
hindquarter amputation compared to those who had
limb sparing surgery. Emotional acceptance was likewise
poor in the hemipelvectomy group. Other series [7,8]
have observed similar results. We found that the reasons
for the poor emotional acceptance are largely due to loss
of mobility and the common complication of phantom
limb pain.
In addition, patients who underwent external hemipelvec-
tomy in the current series had the highest rate of wound
infection at 56%. They also had the worst survival rate
with only 11% of patients alive at the time of follow-up.
These figures are supported by Masterson et al [9] who
reported a 79% incidence of wound infection and 8
deaths within a year among 22 patients. These results fur-
ther support the view that careful patient selection is
required for hindquarter amputation. In recent years,
hemipelvectomy is only performed for patients in whom
extensive bone or soft tissue resection makes reconstruc-
tion difficult or leaves the leg with poor function. Involve-
ment of the sciatic nerve necessitating resection of the
nerve has not been considered a contraindication to limb-
sparing surgery [10].
With Limb-Sparing Surgery, Type 3 and Type 4 resections
had the best results when the function is examined sepa-
rately from the emotional acceptance component. On the
other hand, resections that involve the hip joint confer the
worst results. The reason could be the many problems
associated the methods of reconstruction.
Ischiofemoral arthrodesis and pseudoarthrosis are associ-
ated with shortening of the leg and lack of mobility [11].
The restricted range of flexion and extension permitted at
the pubic symphysis may also result in aching symptoms.
They also have long consolidation times, which means
patients require longer periods of rehabilitation and use
of gait support. Enneking [10] and Menendez [12] found
that the maximum possible activity was achieved after an
average rehabilitation period of 14.2 months.
Saddle prosthesis is suited for bridging large area of defect
in cases where part of the iliac crest could be preserved.
This form of endoprosthetic replacement provides good
cosmetic result [11]. However, the eccentric position of
the new hip center reduces the range of movement. More-
over, if major parts of the ilium were resected, loosening
of the prosthesis with lateral shift of the prosthesis could
be a long-term problem [7]. In this regard, Dacron ties
have been advocated for use to secure the saddle while a
pseudo – capsule develops [13]. In the current series, 3 out
of 9 patients had dislocation of the prosthesis.
There are other alternatives, which include reconstruction
with allografts with or without hip arthroplasty. This was
performed for 3 patients in the current series. Their overallInternational Seminars in Surgical Oncology 2005, 2:9 http://www.issoonline.com/content/2/1/9
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functional result was only fair to satisfactory but all had
high emotional acceptance score. Langlais et al [14]
found, in a small series of 12 patients, 8 patients had good
to excellent overall functional results. Bell at al [15] in a
larger series of 17 patients similarly found a high func-
tional result among his patients. However, there are major
complications associated with this procedure in particular
deep infection and graft disintegration. The risks of these
complications are relatively high [16]. Moreover, this pro-
cedure is restricted by the availability of allograft bone
[17].
Regardless of the functional outcome, it is interesting that
most patients except those who had amputation found
the procedure acceptable. This is supported by Hillmann
et al [2] who also found high acceptance scores for all
types of resection except amputation and acetabular resec-
tion with pelvic prosthetic reconstruction. The high emo-
tional acceptance of patients is probably the most
important factor that advocates pelvic resections: particu-
larly limb sparing surgery.
It should be noted that the recent introduction of transx-
emic acid has had a significant impact in the reduction of
operative bleeding and need for blood transfusion. Tran-
sxemic acid has been shown to be effective in many types
of surgery including major cardiac surgery, liver transplan-
tation, and hip and knee arthroplasty [18-21]. Although
not examined in the current study, its use in pelvic surgery
will likely to have the same beneficial effect.
Conclusion
Pelvic surgery is challenging. The morbidity may be great
and requirements on technical and human resources are
high. Disease control is similar to limb tumours. Func-
tional result and emotional acceptance of patients are gen-
erally high. The relief of pain and improvement in
function in both curative and palliative setting is
extremely rewarding. Major pelvic resection for malig-
nancy appears justified.
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